Shuling Wang
机构:Shenyang Pharmaceutical University, Hebei Medical University, Guangzhou University of Chinese Medicine, University of Science and Technology of China, Fujian Medical University, Naval Medical Research Command, Central South University, Southwest University, Hangzhou Normal University, Shanxi Medical University, Xuzhou Medical College, Second Military Medical University, Hainan University, Naval University of Engineering, National Clinical Research Center for Digestive Diseases, Second Hospital of Hebei Medical University, Changhai Hospital, First Affiliated Hospital of Hebei Medical University, Union Hospital, First Affiliated Hospital of Wannan Medical College
发表论文 267 篇 · 总被引 4745 次 · h-index 34
代表论文
- Mitochondrial damage-associated molecular patterns: New perspectives for mitochondria and inflammatory bowel diseases (2025 · Mucosal Immunology · 被引 15)
- SNAI2 enhances HPV‑negative cervical cancer cell dormancy by modulating u‑PAR expression and the activity of the ERK/p38 signaling pathway in vitro (2024 · Oncology Reports · 被引 9)
- pH-responsive nanocomplex for active transport of aPD-1 and PTX to enhance cancer chemoimmunotherapy (2025 · Nano Today · 被引 7)
- Engineering M1 macrophages with targeting aptamers for enhanced adoptive immunotherapy by modifying the cell surface (2024 · Biomedicine & Pharmacotherapy · 被引 7)
- H2BC9 lactylation modulates esophageal squamous cell carcinoma progression via the Wnt/β-catenin signaling pathway (2025 · Journal of Translational Medicine · 被引 6)
- VTA dopaminergic neurons involved in chronic spared nerve injury pain-induced depressive-like behavior (2025 · Brain Research Bulletin · 被引 6)